Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
August 07 2024 - 4:15PM
Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for
active healing, today announced that Mark Singleton, senior vice
president and chief financial officer, will participate in a
fireside chat at the Canaccord Genuity Global Growth Conference on
Wednesday, August 14, 2024, at 9:00 a.m. ET.
A live webcast of the presentation, followed by a
question-and-answer session will be available on the “Investors”
section of the Company’s website at www.bioventus.com and will be
available for replay on that site following the event.
About BioventusBioventus delivers clinically
proven, cost-effective products that help people heal quickly and
safely. Its mission is to make a difference by helping patients
resume and enjoy active lives. The Innovations for Active Healing
from Bioventus include offerings for Pain Treatments, Restorative
Therapies and Surgical Solutions. Built on a commitment to high
quality standards, evidence-based medicine and strong ethical
behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.bioventus.com, and follow the
Company on LinkedIn and Twitter. Bioventus and the Bioventus logo
are registered trademarks of Bioventus LLC.
Investor and Media Contact:Dave
Crawford919-474-6787dave.crawford@bioventus.com
Bioventus (NASDAQ:BVS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Bioventus (NASDAQ:BVS)
Historical Stock Chart
From Dec 2023 to Dec 2024